title: Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.
authors.forename: Elaine
authors.initials: E
authors.lastname: Weiner
authors.forename: Alison
authors.initials: A
authors.lastname: Buchholz
authors.forename: Agnes
authors.initials: A
authors.lastname: Coffay
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
authors.forename: Robert P
authors.initials: RP
authors.lastname: McMahon
authors.forename: Robert W
authors.initials: RW
authors.lastname: Buchanan
authors.forename: Deanna L
authors.initials: DL
authors.lastname: Kelly
mesh_terms: D000328:Adult; D001552:Benzazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D010865:Pilot Projects; D011810:Quinoxalines / Q000627:therapeutic use*; D012559:Schizophrenia; D016540:Smoking Cessation / Q000379:methods*; D016896:Treatment Outcome; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline